Veterinary Parasiticides Market Size, Share & Trends Analysis Report By Animal Type (Production, Companion) By Product, By Route of Administration, Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

Veterinary Parasiticides Market Size, Share & Trends Analysis Report By Animal Type (Production, Companion) By Product, By Route of Administration, Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030


Veterinary Parasiticides Market Growth & Trends

The global veterinary parasiticides market size is expected to reach USD 16.63 billion by 2030, registering a CAGR of 8.50% from 2024 to 2030, according to a new report by Grand View Research, Inc. Primary market growth drivers include rising demand for pathogen-free meat products and the need for a regulated approach towards parasiticides use. In recent years, with increasing meat consumption, it has been observed that transmission of diseases from meat products has increased. According to an August 2023 study published in the International Journal of Food Microbiology, out of the total studied disease outbreaks from 1991 to 2021, the majority, i.e., 42.4%, were transmitted through meat production establishments. Regarding types of meat, beef & pork were identified to be responsible for 62.35% & 32.1% of the outbreaks, respectively. Such incidences have led to a rise in demand for pathogen-free meat products.

In response, meat producers are employing various strategies before harvesting the meat from the animals to reduce the risk of transmission of foodborne pathogens. Some of these strategies are reducing the number of pathogens entering processing plants, reducing horizontal pathogen spread from infected animals during transport, reducing the pathogen burden in the environment (e.g., dust and pen surfaces), and administering proper treatment regimens to the animals to reduce the risk of getting infected.

Furthermore, animal farms are also breeding & raising specific pathogen-free (SPF) animals free of selected pathogens like parasites, bacteria & viruses, which can potentially transmit diseases to humans. A history of regular pathogen testing and meticulous biosecurity planning for managing housing, environmental, and husbandry factors is essential for producing and preserving SPF animals. Comprehensive risk analysis and exclusion procedures based on an in-depth understanding of the pathogen lifecycle and modes of transmission are vital elements of successful programs. These SPF animals, like pigs, cattle, and poultry, can be used in producing pathogen-free dairy and meat and research activities.

This is a major market driver because, as the production and demand for pathogen-free meat products increase, so will the requirement for products like parasiticides to eliminate the harmful pathogens from these animals and produce a healthy and pathogen-free yield.

However, a major factor that could hamper market growth is the development of antiparasitic drug resistance among animals. In recent years, various research studies have started revealing the rise in antiparasitic drug resistance among animals. For instance, a March 2023 study by the University of Calgary revealed a consistent rise in drug resistance among gastrointestinal worms in the studied pet dogs. Until now, antiparasitic resistance wasn’t considered a major problem among companion animals. However, this growing resistance points towards the fact that in the near future, many routine drug treatments may be ineffective. Therefore, selective use of antiparasitic drugs and thorough research into revealing such instances in other animals is required to resist the negative impact of this factor on the market.

Veterinary Parasiticides Market Report Highlights
  • Based on animal type, the production animal segment held the dominant revenue share of 58.21% in in 2023. This growth can be attributed to increasing demand for animal products and the use of parasiticides in the prevention and treatment of parasitic infections among production animals.
  • Based on product, the ectoparasiticides segment dominated the market with a revenue share of 48.81% in 2023. Ectoparasiticides are preferred over endectocides for treating external parasites like ticks, fleas, and lice due to their targeted action and cost-effectiveness. These products come in various formulations like sprays, powders, ointments, creams, and spot-on treatments. These multiple formulations give these products the advantage over others, as animal owners and veterinary professionals can easily choose the formulation that best suits the target animal.
  • Based on the route of administration, the topical segment dominated market with a revenue share of over 40% in 2023. This can be attributable to the fact that this route of administration is primarily used to treat external parasites like ticks, fleas, and worms in animals through ectoparasiticides. The external application ensures that the parasiticides deal only with the external parasites on the animal's skin and fur and do not directly interact with other essential organisms in animals, minimizing the possible side effects.
  • Based on the distribution channel, the hospital/clinic pharmacy segment dominated the market in 2023. This can be attributable to the availability of a wide variety of parasiticides in these settings. Various animals, such as horses, dogs, cats, and livestock, visit these hospitals/clinics to treat various diseases. After the consultation and diagnosis, the veterinarian can prescribe the required medications to the animal owners, which they can easily procure from the pharmacy present at the hospital or clinic.
  • North America accounted for the largest revenue share in 2023 and is expected to grow at a significant CAGR from 2024 to 2030. This is attributed to the fact that the region is among the top meat-producing countries and has the highest pet adoption rate in the world. These factors contribute to the region's rise in demand for parasiticide products.
  • The Asia Pacific (APAC) market is expected to grow at the fastest CAGR from 2024 to 2030 due to growing initiatives to spread awareness about the diagnosis and treatment of veterinary parasitic infections. Recognizing the growing disease burden of parasitic infections and their zoonoses, the World Organization of Animal Health (WOAH) is actively arranging awareness initiatives to prevent and control parasitic infection zoonoses.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. Global Market: CAGR Calculation
1.8. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Veterinary Parasiticides Market Variable Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market
3.1.2. Ancillary Market
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rise in Parasitic Infections Among Animals
3.2.1.2. Need for Regulated Approach Towards Parasiticide Use
3.2.1.3. Rise in Medicalization Rate Among Animals
3.2.1.4. Rising Demand for Pathogen-free Meat Products
3.2.2. Market Restraint Analysis
3.2.2.1. Rise in Antiparasitic Resistance
3.2.2.2. Ecological Impacts of Veterinary Parasiticides
3.2.2.3. Stringent Regulations
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Veterinary Parasiticides Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitution
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.3. Regulatory Framework
3.3.4. Estimated Animal Population, by Key Species, by Key Countries, 2018-2023
3.3.5. COVID-19 Impact Analysis
Chapter 4. Veterinary Parasiticides Market: Animal Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Veterinary Parasiticides Market: Animal type Movement Analysis
4.3. Veterinary Parasiticides Market Size & Trend Analysis, by animal type, 2018 to 2030 (USD Million)
4.4. Production Animal
4.4.1. Production Animal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Cattle
4.4.2.1. Cattle Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Swine
4.4.3.1. Swine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4. Poultry
4.4.4.1. Poultry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.5. Others (sheep, goats, aquaculture, etc.)
4.4.5.1. Others (sheep, goats, aquaculture, etc.) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Companion Animal
4.5.1. Companion Animal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. Canine
4.5.2.1. Canine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3. Feline
4.5.3.1. Feline Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.4. Equine
4.5.4.1. Equine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.5. Others (turtles, fish, rabbits, etc.)
4.5.5.1. Others (turtles, fish, rabbits, etc.) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Veterinary Parasiticides Market: Product Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Veterinary Parasiticides Market: Product Movement Analysis
5.3. Veterinary Parasiticides Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
5.4. Ectoparasiticides
5.4.1. Ectoparasiticides Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Endoparasiticides
5.5.1. Endoparasiticides Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Endectocides
5.6.1. Endectocides Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Veterinary Parasiticides Market: By Route of Administration Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Veterinary Parasiticides Market: By Route of Administration Movement Analysis
6.3. Veterinary Parasiticides Market Size & Trend Analysis, by route of administration, 2018 to 2030 (USD Million)
6.3.1. Oral
6.3.1.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. Injectable
6.3.2.1. Injectable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Topical
6.3.3.1. Topical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Veterinary Parasiticides Market: By Distribution Channel Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Veterinary Parasiticides Market: By Distribution Channel Movement Analysis
7.3. Veterinary Parasiticides Market Size & Trend Analysis, by distribution channel, 2018 to 2030 (USD Million)
7.3.1. Retail
7.3.1.1. Retail Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. E-Commerce
7.3.2.1. E-Commerce Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Hospital/Clinic Pharmacy
7.3.3.1. Hospital/Clinic Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. Others (government campaigns, etc.)
7.3.4.1. Others (government campaigns, etc.) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Veterinary Parasiticides Market: Regional Estimates & Trend Analysis
8.1. Regional Dashboard
8.2. Veterinary Parasiticides Market Share, By Region, 2023 & 2030, USD Million
8.3. Regional Outlook
8.4. North America
8.4.1. North America Veterinary Parasiticides Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.2. U.S.
8.4.2.1. Key Country Dynamics
8.4.2.2. U.S. Veterinary Parasiticides Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.3. Canada
8.4.3.1. Key Country Dynamics
8.4.3.2. Canada Veterinary Parasiticides Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.4. Mexico
8.4.4.1. Key Country Dynamics
8.4.4.2. Mexico Veterinary Parasiticides Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5. Europe
8.5.1. Europe Veterinary Parasiticides Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.2. UK
8.5.2.1. Key Country Dynamics
8.5.2.2. UK Veterinary Parasiticides Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.3. Germany
8.5.3.1. Key Country Dynamics
8.5.3.2. Germany Veterinary Parasiticides Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.4. France
8.5.4.1. Key Country Dynamics
8.5.4.2. France Veterinary Parasiticides Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.5. Italy
8.5.5.1. Key Country Dynamics
8.5.5.2. Italy Veterinary Parasiticides Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.6. Spain
8.5.6.1. Key Country Dynamics
8.5.6.2. Spain Veterinary Parasiticides Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.7. Denmark
8.5.7.1. Key Country Dynamics
8.5.7.2. Denmark Veterinary Parasiticides Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.8. Sweden
8.5.8.1. Key Country Dynamics
8.5.8.2. Sweden Veterinary Parasiticides Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.9. Norway
8.5.9.1. Key Country Dynamics
8.5.9.2. Norway Veterinary Parasiticides Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific Veterinary Parasiticides Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.2. Japan
8.6.2.1. Key Country Dynamics
8.6.2.2. Japan Veterinary Parasiticides Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.3. China
8.6.3.1. Key Country Dynamics
8.6.3.2. China Veterinary Parasiticides Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.4. India
8.6.4.1. Key Country Dynamics
8.6.4.2. India Veterinary Parasiticides Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.5. Australia
8.6.5.1. Key Country Dynamics
8.6.5.2. Australia Veterinary Parasiticides Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.6. South Korea
8.6.6.1. Key Country Dynamics
8.6.6.2. South Korea Veterinary Parasiticides Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.7. Thailand
8.6.7.1. Key Country Dynamics
8.6.7.2. Thailand Veterinary Parasiticides Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7. Latin America
8.7.1. Latin America Veterinary Parasiticides Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7.2. Brazil
8.7.2.1. Key Country Dynamics
8.7.2.2. Brazil Veterinary Parasiticides Market Estimates And Forecasts, 2018 - 2030
8.7.3. Argentina
8.7.3.1. Key Country Dynamics
8.7.3.2. Argentina Veterinary Parasiticides Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8. Middle East & Africa
8.8.1. Middle East & Africa Veterinary Parasiticides Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.2. South Africa
8.8.2.1. Key Country Dynamics
8.8.2.2. South Africa Veterinary Parasiticides Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key Country Dynamics
8.8.3.2. Saudi Arabia Veterinary Parasiticides Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.4. UAE
8.8.4.1. Key Country Dynamics
8.8.4.2. UAE Veterinary Parasiticides Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key Country Dynamics
8.8.5.2. Kuwait Veterinary Parasiticides Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.2. Company Market Position Analysis/ Heap Map Analysis
9.3. Company Profiles
9.3.1. Zoetis
9.3.1.1. Participant’s Overview
9.3.1.2. Financial Performance
9.3.1.3. Product Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Boehringer Ingelheim
9.3.2.1. Participant’s Overview
9.3.2.2. Financial Performance
9.3.2.3. Product Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Merck & Co. Inc.
9.3.3.1. Participant’s Overview
9.3.3.2. Financial Performance
9.3.3.3. Product Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Dechra Pharmaceuticals Plc.
9.3.4.1. Participant’s Overview
9.3.4.2. Financial Performance
9.3.4.3. Product Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Elanco Animal Health
9.3.5.1. Participant’s Overview
9.3.5.2. Financial Performance
9.3.5.3. Product Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Ceva Sante Animale
9.3.6.1. Participant’s Overview
9.3.6.2. Financial Performance
9.3.6.3. Product Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Virbac
9.3.7.1. Participant’s Overview
9.3.7.2. Financial Performance
9.3.7.3. Product Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Biogenesis Bago
9.3.8.1. Participant’s Overview
9.3.8.2. Financial Performance
9.3.8.3. Product Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Vetoquinol
9.3.9.1. Participant’s Overview
9.3.9.2. Financial Performance
9.3.9.3. Product Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. Himalaya Wellness
9.3.10.1. Participant’s Overview
9.3.10.2. Financial Performance
9.3.10.3. Product Benchmarking
9.3.10.4. Strategic Initiatives
9.4. Strategy Mapping
9.4.1. Mergers & Acquisitions
9.4.2. Partnerships & Collaborations
9.4.3. Expansion
9.4.4. Product launch
9.4.5. Product Approval
9.4.6. Others
9.5. List of Key Companies
9.5.1. List of Manufacturers
9.5.2. List of Distributors

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings